Open Beta
TREN
MetriLume
TREN

US marketsCNTB

SEC-sourced researchBeta

CNTB

Connect Biopharma Holdings Ltd

Company comparison ↗

Data passport

CIK
0001835268
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 6, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 26,033,000.0000 USD; December 2025: 64,000.0000 USD26M USD0 USD0December 2024December 2025
CNTB · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202426,033,000.0000Mar 31, 2026
December 202564,000.0000Mar 31, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202564,000.0000-55,480,000.0000-51,206,000.000056,075,000.000014,095,000.0000Mar 31, 2026
December 202426,033,000.0000-15,628,000.0000-23,612,000.0000101,284,000.00009,118,000.0000Mar 31, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$64KDecember 2025Mar 31, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$26.03MDecember 2024Mar 31, 202610-K
Net incomeNetIncomeLoss-$55.48MDecember 2025Mar 31, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$51.21MDecember 2025Mar 31, 202610-K
Total assetsAssets$56.08MDecember 2025Mar 31, 202610-K
Total liabilitiesLiabilities$14.1MDecember 2025Mar 31, 202610-K

New filings

Explore methodology ↗